On this episode of Stock Movers:

- Novo Nordisk (NVO) dropped after a pill version of Ozempic failed to slow the progression of Alzheimer’s disease in a pair of long-shot studies that aimed to open up a new use for blockbuster obesity drugs.

- Amazon (AMZN) is rising. The company says it will spend as much as $50 billion, expanding its capacity to provide artificial intelligence and high-performance computing services to US government entities.

- Tesla (TSLA) shares jumped around 7% on Monday after a Sunday post on X from Elon Musk commenting on the company’s AI chip plans.

On this episode of Stock Movers:
- Novo Nordisk (NVO) dropped after a pill version of Ozempic failed to slow the progression of Alzheimer&rsquo;s disease in a pair of long-shot studies that aimed to open up a new use for blockbuster obesity drugs.
- Amazon (AMZN) is rising. The company says it will spend as much as $50 billion, expanding its capacity to provide artificial intelligence and high-performance computing services to US government entities.
- Tesla (TSLA) shares jumped around 7% on Monday after a Sunday post on X from Elon Musk commenting on the company&rsquo;s AI chip plans.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for five-minute conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Novo Nordisk's Ozempic Pill Fails to Slow Alzheimer's, Amazon Rises, Tesla Jumps

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/9ca8b197-dad8-448d-885c-b39f014c4c47/transcript

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Associated British Foods will separate budget clothing chain Primark and break up one of the UK’s biggest conglomerates after more than three decades.
- Crest Nicholson shares tumble as much as 44% to a record low as the UK homebuilder cuts full-year earnings guidance due to economic uncertainty and softening land sales that have caused it to prioritize cash preservation.
- The UK will seek to speed up efforts to cut the costs of green electricity by reducing its exposure to more expensive gas. SSE shares rose as much as 4% in early trading.

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Associated British Foods will separate budget clothing chain Primark and break up one of the UK&rsquo;s biggest conglomerates after more than three decades. - Crest Nicholson shares tumble as much as 44% to a record low as the UK homebuilder cuts full-year earnings guidance due to economic uncertainty and softening land sales that have caused it to prioritize cash preservation. - The UK will seek to speed up efforts to cut the costs of green electricity by reducing its exposure to more expensive gas. SSE shares rose as much as 4% in early trading.

AB Foods Falls, Crest Nicholson Tumbles, SSE

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/a5ebd3c0-2d40-4425-8382-b43300870c28/transcript

Today's biggest winners and losers in the stock market.

On this episode of Stock Mover

- Apple (AAPL) named hardware chief John Ternus as the iPhone maker’s next leader, with Chief Executive Officer Tim Cook shifting to the role of executive chairman. Ternus, 50, will become CEO on Sept. 1, the company said in a statement Monday. The Apple veteran was head of hardware engineering since 2021 and has spent 25 years focused on product development at the iPhone maker. Bloomberg News previously reported that Ternus was Cook’s heir apparent. Shares slipped afterhours.

- Amazon (AMZN) is investing an additional $5 billion in Anthropic, and may inject $20 billion more over time, a deal that deepens the companies’ ties in an increasingly competitive artificial intelligence industry. Anthropic, which makes the Claude chatbot and coding tool, plans to spend more than $100 billion over the next 10 years on Amazon’s cloud technologies and chips, the companies said in a statement on Monday. Amazon shares gained more than 3% on the news in after-hours trading.

- Compass Pathways (CMPS) as well as shares of other psychedelic-linked companies surged in trading after President Donald Trump signed an executive order to expedite research and access. The new order directs the US Food and Drug Administration to issue expedited review vouchers to psychedelics with a so-called breakthrough designation, shortening the review time to one to two months from six to ten months. AtaiBeckley, Definium and Compass Pathways all have therapies with breakthrough status.

Today's biggest winners and losers in the stock market.
On this episode of Stock Mover
- Apple (AAPL) named hardware chief John Ternus as the iPhone maker&rsquo;s next leader, with Chief Executive Officer Tim Cook shifting to the role of executive chairman. Ternus, 50, will become CEO on Sept. 1, the company said in a statement Monday. The Apple veteran was head of hardware engineering since 2021 and has spent 25 years focused on product development at the iPhone maker. Bloomberg News previously reported that Ternus was Cook&rsquo;s heir apparent. Shares slipped afterhours.
- Amazon (AMZN) is investing an additional $5 billion in Anthropic, and may inject $20 billion more over time, a deal that deepens the companies&rsquo; ties in an increasingly competitive artificial intelligence industry. Anthropic, which makes the Claude chatbot and coding tool, plans to spend more than $100 billion over the next 10 years on Amazon&rsquo;s cloud technologies and chips, the companies said in a statement on Monday. Amazon shares gained more than 3% on the news in after-hours trading.
- Compass Pathways (CMPS) as well as shares of other psychedelic-linked companies surged in trading after President Donald Trump signed an executive order to expedite research and access. The new order directs the US Food and Drug Administration to issue expedited review vouchers to psychedelics with a so-called breakthrough designation, shortening the review time to one to two months from six to ten months. AtaiBeckley, Definium and Compass Pathways all have therapies with breakthrough status.

Apple Slips on CEO Shakeup, Amazon Falls, Compass Pathways Soars 

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/c2572b8d-746c-4dbf-8453-b43201648e6d/transcript

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers: 

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec.

- USA Rare Earth (USAR) rose after the company agreed to acquire Brazil’s Serra Verde Group in a $2.8 billion cash-and-stock transaction, marking one of the largest deals in the rare-earths industry. 

- Psychedelic-linked firms like Compass Pathways (CMPS) skyrocketed after President Trump signed a weekend executive order to expedite research and access. US-traded shares of Compass Pathways spiked as much as 53% while AtaiBeckley surged by 37%. GH Research PLC jumped 34% and Definium Therapeutics, Inc. rallied 16%. The AdvisorShares Psychedelics ETF (PSIL) also climbed as much as 20% — touching its highest intraday level since July 2023.

- AST SpaceMobile (AST) shares dropped as much as 14% after Blue Origin’s flagship New Glenn rocket failed to correctly place a satellite made by the Texas-based company in its intended orbit.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:&nbsp;
Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec.
- USA Rare Earth (USAR) rose after the company agreed to acquire Brazil&rsquo;s Serra Verde Group in a $2.8 billion cash-and-stock transaction, marking one of the largest deals in the rare-earths industry.&nbsp;
- Psychedelic-linked firms like Compass Pathways (CMPS) skyrocketed after President Trump signed a weekend executive order to expedite research and access. US-traded shares of Compass Pathways spiked as much as 53% while AtaiBeckley surged by 37%. GH Research PLC jumped 34% and Definium Therapeutics, Inc. rallied 16%. The AdvisorShares Psychedelics ETF (PSIL) also climbed as much as 20% &mdash; touching its highest intraday level since July 2023.
- AST SpaceMobile (AST) shares dropped as much as 14% after Blue Origin&rsquo;s flagship New Glenn rocket failed to correctly place a satellite made by the Texas-based company in its intended orbit.

Closing Bell: USA Rare Earth Rises, Psychedelic-Linked Stocks Rally, AST SpaceMobile Drops

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/ca60d295-0702-4ca2-8503-b4320162732a/transcript

Novo Nordisk's Ozempic Pill Fails to Slow Alzheimer's, Amazon Rises, Tesla Jumps

In 1 playlist(s)

Stock Movers

Social links

Follow podcast

Recent clips